As with any supplement, it is crucial to use it in recommended doses and consult with a healthcare provider
Chemotherapy-Induced Polyneuropathy Chemotherapy-induced peripheral polyneuropathy affects up to 80% of patients treated and constitutes a series adverse event, the occurrence of which may require anti-cancer therapy dose adjustment [69]
Recently, studies have identified loss of trimethylation at lysine 27 of histone H3 (H3K27me3) in a subset of malignant peripheral nerve sheath tumors reflecting inactivation of the polycomb repressive complex 2 (PRC2), resulting from inactivating mutations of its constituents SUZ12 or EED
The safety data comes primarily from animal studies, with human use data coming from clinical practice rather than formal trials
Tani, K., Mizoguchi, T., Iwamatsu, A., Hatsuzawa, K